DE3588218D1 - Von Blutplättchen abstammende biologisch aktive Analoga eines Wachstumsfaktors in eukaryotischen Zellen - Google Patents

Von Blutplättchen abstammende biologisch aktive Analoga eines Wachstumsfaktors in eukaryotischen Zellen

Info

Publication number
DE3588218D1
DE3588218D1 DE3588218T DE3588218T DE3588218D1 DE 3588218 D1 DE3588218 D1 DE 3588218D1 DE 3588218 T DE3588218 T DE 3588218T DE 3588218 T DE3588218 T DE 3588218T DE 3588218 D1 DE3588218 D1 DE 3588218D1
Authority
DE
Germany
Prior art keywords
pdgf
chain
factor
biologically active
secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3588218T
Other languages
English (en)
Other versions
DE3588218T2 (de
Inventor
Mark Joseph Murray
James Darrel Kelly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45478613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3588218(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/660,496 external-priority patent/US4769328A/en
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of DE3588218D1 publication Critical patent/DE3588218D1/de
Application granted granted Critical
Publication of DE3588218T2 publication Critical patent/DE3588218T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/11011—Alpharetrovirus, e.g. avian leucosis virus
    • C12N2740/11022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related
DE3588218T 1984-10-12 1985-10-10 Von Blutplättchen abstammende biologisch aktive Analoga eines Wachstumsfaktors in eukaryotischen Zellen Expired - Lifetime DE3588218T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/660,496 US4769328A (en) 1984-10-12 1984-10-12 Expression of biologically active PDGF analogs in yeast
US06/705,175 US4801542A (en) 1984-10-12 1985-02-25 Expression of biologically active PDGF analogs in eucaryotic cells
CA000492370A CA1340212C (en) 1984-10-12 1985-10-07 Expression of biologically active platelet derived growth factor analogsin eucaryotic cells
CA 617115 CA1340846E (en) 1984-10-12 1999-06-11 Expression of biologically active platelet derived growth factor analogs in eucaryotic cells

Publications (2)

Publication Number Publication Date
DE3588218D1 true DE3588218D1 (de) 2000-02-03
DE3588218T2 DE3588218T2 (de) 2000-05-18

Family

ID=45478613

Family Applications (4)

Application Number Title Priority Date Filing Date
DE199191121387T Pending DE487116T1 (de) 1984-10-12 1985-10-10 Von blutplaettchen abstammende biologisch aktive analoga eines wachstumsfaktors in eukaryotischen zellen.
DE1999175042 Active DE19975042I2 (de) 1984-10-12 1985-10-10 Expression in Hefezellen, von biologisch aktiven Analoga eines Wachstumsfaktors, abstammend von Blutplättchen.
DE3588218T Expired - Lifetime DE3588218T2 (de) 1984-10-12 1985-10-10 Von Blutplättchen abstammende biologisch aktive Analoga eines Wachstumsfaktors in eukaryotischen Zellen
DE3586960T Expired - Lifetime DE3586960T3 (de) 1984-10-12 1985-10-10 Expression in Hefezellen, von biologisch aktiven Analoga eines Wachstumsfaktors, abstammend von Blutplättchen

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE199191121387T Pending DE487116T1 (de) 1984-10-12 1985-10-10 Von blutplaettchen abstammende biologisch aktive analoga eines wachstumsfaktors in eukaryotischen zellen.
DE1999175042 Active DE19975042I2 (de) 1984-10-12 1985-10-10 Expression in Hefezellen, von biologisch aktiven Analoga eines Wachstumsfaktors, abstammend von Blutplättchen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE3586960T Expired - Lifetime DE3586960T3 (de) 1984-10-12 1985-10-10 Expression in Hefezellen, von biologisch aktiven Analoga eines Wachstumsfaktors, abstammend von Blutplättchen

Country Status (9)

Country Link
US (1) US4801542A (de)
EP (1) EP0177957B2 (de)
JP (2) JP2837407B2 (de)
AT (2) ATE188255T1 (de)
AU (2) AU4845485A (de)
CA (2) CA1340212C (de)
DE (4) DE487116T1 (de)
LU (1) LU90408I2 (de)
NL (1) NL990016I2 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3751632T2 (de) * 1986-08-13 1996-06-13 Zymogenetics Inc Expression von biologisch-aktiven PDGF-Analogen in eukaryotischen Zellen
US5474982A (en) * 1986-08-13 1995-12-12 Zymogenetics, Inc. PDGF analogs and methods of use
US5019559A (en) * 1986-11-14 1991-05-28 President And Fellows Of Harvard College Wound healing using PDGF and IGF-II
JPH01502669A (ja) * 1987-03-13 1989-09-14 アムジエン・インコーポレーテツド 精製された血小板由来の成長因子及びその精製方法
US5219759A (en) * 1987-04-22 1993-06-15 Chiron Corporation Recombinant DNA encoding PDGF A-chain polypeptide and expression vectors
US6939849B1 (en) 1987-04-22 2005-09-06 Chiron Corporation Recombinant PDGF A-chain homodimers and methods of use
EP0288307B1 (de) * 1987-04-22 1996-09-04 Chiron Corporation Rekombinante Herstellung von A-Ketten-Polypeptiden von PDGF
US5094941A (en) * 1987-12-31 1992-03-10 Zymogenetics, Inc. Monoclonal antibodies to PDGF
US5759815A (en) * 1988-02-11 1998-06-02 Creative Biomolecules, Inc. Production of platelet derived growth factor (PDGF) an muteins thereof
WO1990000178A1 (en) * 1988-06-30 1990-01-11 Cor Therapeutics, Inc. Platelet blocking peptides
US5037743A (en) * 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
DE3900770A1 (de) * 1989-01-12 1990-07-26 Juergen Prof Dr Hoppe Verfahren zur herstellung von pdgf-a und pdgf-aa
US6899882B1 (en) * 1989-03-24 2005-05-31 The Regents Of The University Of California Endothelial cell growth factor methods of isolation and expression
US5686410A (en) * 1989-07-20 1997-11-11 Novartis Ag Polypeptide derivatives
US5219739A (en) * 1989-07-27 1993-06-15 Scios Nova Inc. DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
US5272064A (en) * 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
US6172039B1 (en) 1990-04-16 2001-01-09 Apex Bioscience, Inc. Expression of recombinant hemoglobin and hemoglobin variants in yeast
DK0547064T3 (da) * 1990-07-23 1995-03-20 Zymogenetics Inc Proteaseresistent PDGF og anvendelsesfremgangsmåde
US5886141A (en) * 1990-10-26 1999-03-23 Takeda Chemical Industries, Ltd. Smooth muscle mitogen peptides and DNA coding therefor
GB9101645D0 (en) * 1991-01-25 1991-03-06 British Bio Technology Compounds
ES2099304T3 (es) * 1992-02-10 1997-05-16 Takeda Chemical Industries Ltd Mitogeno de la musculatura lisa y adn que lo codifica.
ES2293137T3 (es) 1995-10-11 2008-03-16 Novartis Vaccines And Diagnostics, Inc. Combinacion de pdgf, kgf,igf e igfbp para curacion de heridas.
DE69739319D1 (de) * 1996-12-13 2009-04-30 Novartis Vaccines & Diagnostic Verfahren zur Expression von PDGF oder IGR Proteinen in Hefe
EP1025212B1 (de) 1997-10-14 2007-09-26 Darwin Molecular Corporation Thymidinkinase mutanten und fusionproteine mit thymidinkinase und guanylatekinase aktivitäten
US6194169B1 (en) * 1998-06-04 2001-02-27 The University Of Kentucky Research Foundation Enhanced expression of human platelet-derived growth factor in Pichia pastoris
IL143266A0 (en) 1998-11-27 2002-04-21 Darwin Discovery Ltd Transforming growth factor-beta binding proteins and pharmaceutical compositions for increasing bone mineral content utilizing the same
US20040009535A1 (en) 1998-11-27 2004-01-15 Celltech R&D, Inc. Compositions and methods for increasing bone mineralization
US7063850B1 (en) 1998-12-22 2006-06-20 University Of Tennessee Research Foundation Protective antigen of group A Streptococci
US6358733B1 (en) * 2000-05-19 2002-03-19 Apolife, Inc. Expression of heterologous multi-domain proteins in yeast
DE60228477D1 (de) 2001-05-08 2008-10-02 Darwin Molecular Corp Verfahren zur regulierung der immunfunktion in primaten unter verwendung des foxp3-proteins
WO2003060143A2 (en) * 2001-10-26 2003-07-24 Id Biomedical Corporation Of Washington Efficient protein expression system
CA2472937C (en) 2002-01-11 2014-06-17 Biomarin Pharmaceutical, Inc. Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
US20030139333A1 (en) * 2002-01-18 2003-07-24 Genetix Pharmaceuticals, Inc. Methods and compositions for promoting angiogenesis
US20050048041A1 (en) * 2003-01-13 2005-03-03 Rao Mahendra S. Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
WO2008005533A2 (en) * 2006-07-06 2008-01-10 Aaron Thomas Tabor Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
KR20100014290A (ko) * 2006-11-30 2010-02-10 더 유니버시티 오브 브리티쉬 콜럼비아 분자 아주반트로서 ｔａｐ―１ 및/또는 ｔａｐ―２를 포함하는 폭스비리대 치료
BR112012000865A2 (pt) 2009-07-17 2019-09-24 T Tabor Aaron "composição e método para a modificação genética cosmética de células substancialmente intactas"
JP6208658B2 (ja) 2011-07-05 2017-10-04 バイオアシス テクノロジーズ インコーポレイテッド ｐ９７−抗体結合体および使用方法
EP2739649B1 (de) 2011-08-05 2017-09-27 Bioasis Technologies Inc. P97-fragmente mit transferaktivität
EP2880156B1 (de) 2012-07-31 2017-08-23 biOasis Technologies Inc Dephosphorylierte proteine lysosomaler speicherkrankheiten und verwendung davon
CN105263958B (zh) 2013-03-13 2019-09-27 比奥阿赛斯技术有限公司 p97片段及其应用
AU2014236208B2 (en) 2013-03-14 2018-07-19 Genvivo, Inc. Thymidine kinase diagnostic assay for gene therapy applications
JP6603227B2 (ja) 2014-02-03 2019-11-06 バイオアシス テクノロジーズ インコーポレイテッド Ｐ９７融合タンパク質
DK3107562T3 (da) 2014-02-19 2019-12-16 Bioasis Technologies Inc P97-ids-fusionsproteiner
US10058619B2 (en) 2014-05-01 2018-08-28 Bioasis Technologies, Inc. P97-polynucleotide conjugates
JP6871855B2 (ja) 2014-10-14 2021-05-19 サムエル リンチ， 創傷を処置するための組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350687A (en) * 1980-02-10 1982-09-21 Research Corporation Platelet derived cell growth factor
AU600885B2 (en) * 1984-05-25 1990-08-30 Zymogenetics Inc. Stable DNA constructs

Also Published As

Publication number Publication date
EP0177957B2 (de) 2004-08-25
AU4845485A (en) 1986-04-17
EP0177957A3 (en) 1988-02-03
ATE84312T1 (de) 1993-01-15
DE3588218T2 (de) 2000-05-18
JPS62278A (ja) 1987-01-06
NL990016I1 (nl) 1999-08-02
JPH10117790A (ja) 1998-05-12
DE3586960T3 (de) 2005-01-20
EP0177957B1 (de) 1993-01-07
NL990016I2 (nl) 1999-11-01
AU638010B2 (en) 1993-06-17
JP3145968B2 (ja) 2001-03-12
LU90408I2 (fr) 1999-08-25
AU5488590A (en) 1991-01-31
DE3586960D1 (de) 1993-02-18
DE487116T1 (de) 1992-10-15
CA1340846E (en) 1999-12-07
CA1340212C (en) 1998-12-15
EP0177957A2 (de) 1986-04-16
DE3586960T2 (de) 1993-05-13
ATE188255T1 (de) 2000-01-15
US4801542A (en) 1989-01-31
DE19975042I2 (de) 2004-01-29
JP2837407B2 (ja) 1998-12-16

Similar Documents

Publication Publication Date Title
DE3588218D1 (de) Von Blutplättchen abstammende biologisch aktive Analoga eines Wachstumsfaktors in eukaryotischen Zellen
KR910015309A (ko) 종양괴사인자(tnf) 억제제 및 그 제조방법
NO174965C (no) Syntetisk polypeptidanalog av humaninsulinlignende vekstfaktor med redusert binding til bærerproteiner i serum, samt syntetiske gener som koder for slike analoger og preparater som omfatter en slik analog
DE69020335D1 (de) B-ketten-analoge des von blutplättchen abstammenden wachstumsfaktors und verfahren zu deren homogener herstellung.
IL88223A0 (en) Polypeptides,process,nucleotide sequences,expression vectors and host organisms for their production and pharmaceutical compositions comprising them
ATE90966T1 (de) Expression von protein-c.
ATE50596T1 (de) Fusionsproteine, verfahren zu ihrer herstellung und ihre verwendung.
AU7681687A (en) Expression of platelet-derived growth factor and analogues
DE3688900D1 (de) Expression von protein c.
EP0111814A3 (de) Klonierung und Expression von nucleotiden Sequenzen die für Rinderwachstumshormon kodieren
GR3015689T3 (en) Process for the construction of an animal cell line for the production of human beta-interferon.
PT82860B (pt) Metodo para a producao da hormona de crescimento suina
JPS6437291A (en) Human cytochrome c gene and use thereof
HUP9800520A2 (hu) Génexpresszió emlős sejtekben
WO1991009951A3 (en) Recombinant protein c with truncated light chain
JPS54110384A (en) Culturing medium for humanized lymphocyte

Legal Events

Date Code Title Description
8364 No opposition during term of opposition